Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Slides:

Advertisements

Similar presentations

What Predicts Long-Term Survival After Heart Transplantation

Advertisements

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile Todd C. Crawford, MD, Joshua C. Grimm, MD, J.

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Late Vascular Complications After Extracorporeal Membrane Oxygenation Support Daniel Zimpfer, MD, Birgit Heinisch, MD, Martin Czerny, MD, Thomas Hoelzenbein,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Joshua E. Rosen, BASc, Hari B

Variation in Red Blood Cell Transfusion Practices During Cardiac Operations Among Centers in Maryland: Results From a State Quality-Improvement Collaborative

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Rika E. Ohkuma, MD, Todd C. Crawford, MD, Patricia M

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Less Is More: Results of a Statewide Analysis of the Impact of Blood Transfusion on Coronary Artery Bypass Grafting Outcomes Todd C. Crawford, MD, J.

Castigliano M. Bhamidipati, DO, MS, George J

Complications After Cardiac Operations: All Are Not Created Equal

Less Is More in Post Pediatric Heart Transplant Care

The Effect of Institutional Volume on Complications and Their Impact on Mortality After Pediatric Heart Transplantation Cecillia Lui, MD, Joshua C. Grimm,

Operative Results and Outcomes in Children With Shone's Anomaly

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Origins of the Cardiothoracic Surgery Network (CTSNet)

Joshua C. Grimm, MD, J. Trent Magruder, MD, Rika Ohkuma, MD, Samuel P

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Ross Versus Non-Ross Aortic Valve Replacement in Children: A 22-Year Single Institution Comparison of Outcomes John W. Brown, MD, Parth M. Patel, BS,

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Michael Lanuti, MD, Pierre E

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

J. Trent Magruder, MD, Allen Young, BA, Joshua C. Grimm, MD, John V

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Development and Validation of a Score to Predict the Risk of Readmission After Adult Cardiac Operations Arman Kilic, MD, Jonathan T. Magruder, MD, Joshua.

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Aravind Krishnan, BA, Alejandro Suarez-Pierre, MD, Todd C

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Kara A. Haggerty, BA, Timothy J. George, MD, George J

Kevin L. Greason, MD, Brian D. Lahr, MS, John M

Aortic Root Replacement for Children With Loeys-Dietz Syndrome

William M. Whited, MD, Paul Henley, BS, Erin M

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

A. Thomas Pezzella, MD, Sari D

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Predictive Risk Factors for Patients With Cirrhosis Undergoing Heart Surgery Rawa Arif, MD, Philipp Seppelt, cand med, Simon Schwill, cand med, Dubravka.

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Completeness of Revascularization and Survival Among Octogenarians With Triple- Vessel Disease Siamak Mohammadi, MD, Dimitri Kalavrouziotis, MD, Francois.

Robert Lee Replogle, September 30, 1931–May 9, 2016

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

The American Board of Thoracic Surgery: Update

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Stefano Zoli, MD, Christian D

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

A Risk Score to Predict Acute Renal Failure in Adult Patients After Lung Transplantation Joshua C. Grimm, MD, Cecillia Lui, BSE, Arman Kilic, MD, Vicente.

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Phillip S. Naimo, BS, Matthew S

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Risk of Valve-Related Events After Aortic Valve Repair

Heart Transplant Program Volume Is Not a Measure of Quality

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Presentation transcript:

The Paradoxical Relationship Between Donor Distance and Survival After Heart Transplantation Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C. Grimm, MD, Clinton D. Kemp, MD, Alejandro Suarez-Pierre, MD, Kenton J. Zehr, MD, Kaushik Mandal, MD, Glenn J. Whitman, MD, John V. Conte, MD, Robert S. Higgins, MD, Duke E. Cameron, MD, Christopher M. Sciortino, MD, PhD The Annals of Thoracic Surgery Volume 103, Issue 5, Pages 1384-1391 (May 2017) DOI: 10.1016/j.athoracsur.2017.01.055 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier (A) 30-day and (B) 1-year survival curve comparisons among donor distance strata. The Annals of Thoracic Surgery 2017 103, 1384-1391DOI: (10.1016/j.athoracsur.2017.01.055) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Risk-adjusted hazard ratios for (A) 30-day and (B) 1-year mortality associated with the donor distance strata. Strata that do not cross 1.0 are considered significant (p < 0.05). The Annals of Thoracic Surgery 2017 103, 1384-1391DOI: (10.1016/j.athoracsur.2017.01.055) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions